SuperworthFractyl Health EPS GUTS
Diluted earnings per share by quarter and over the last twelve months, from 2023.
- Last 12 months, to Jun 30, 2026
- −$13.44
- Latest quarter, Q2 FY26
- −$1.92
- Fiscal year 2025
- −$24.96
Fractyl Health's earnings per share was −$13.44 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$1.92.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$24.96 | n/a |
| FY2024 | −$18.36 | n/a |
| FY2023 | −$543.36 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$1.92 | n/a | −$13.44 | |
| Q1 FY26 | $0.72 | n/a | −$18.36 | |
| Q4 FY25 | −$3.72 | n/a | −$24.96 | |
| Q3 FY25 | −$8.52 | n/a | −$27.48 | |
| Q2 FY25 | −$6.84 | n/a | −$24.72 | |
| Q1 FY25 | −$5.88 | n/a | −$22.20 | |
| Q4 FY24 | −$6.24 | n/a | −$18.36 | |
| Q3 FY24 | −$5.76 | n/a | −$146.28 | |
| Q2 FY24 | −$4.32 | n/a | −$255.84 | |
| Q1 FY24 | −$2.04 | n/a | −$450.96 | |
| Q4 FY23 | −$134.16 | n/a | −$543.36 | |
| Q3 FY23 | −$115.32 | n/a | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Fractyl Health's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| GUTSFractyl Health | −$13.44 | |
| NEPHNephros | $0.16 | +33% a year |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| Peer median | $0.41 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Fractyl Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.